>
Organization
Immunogen Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Immunogen Inc.

... ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... 2019 could be a pivotal year for antibody-drug conjugate specialist ImmunoGen as it tries to draw a line under past challenges with phase ...
... ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... of Blaine McKee, Ph.D., Executive Vice President and Chief Business Officer of ImmunoGen, Inc., to the company's Board of Directors. "Blaine is an excellent addition ...
... Antibody-drug conjugate company ImmunoGen Inc (Nasdaq:IMGN) reported on Monday the divestiture of its residual rights to receive ...
... ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) ...
... a fully human antibody targeting CD205, coupled to the DM4 toxin from Immunogen. OBT076 is being developed for a number of CD205 driven tumors including ...
... Anti-CD19 Antibody Pipeline Insight, 2018 Report Featuring Marino Biotechnology, Xencor, ImmunoGen, MedImmune & Merck - ResearchAndMarkets.com ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/immunogen-inc-o7402
  • https://relationshipscience.com/News/immunogen-inc-o7402
Subscribe now for full coverage on Immunogen Inc.
Start My Free Trial